Within the in vitro diagnostics contract manufacturing market, Reagents & Consumables held a 67.33% share in 2025, making them the clear volume leader across the product segment. This leadership is underpinned by the routine and recurring nature of reagent and consumable demand in diagnostic workflows, where every test run depends on a steady supply of validated inputs. In the in vitro diagnostics contract manufacturing market, outsourcing for these products also aligns well with customers’ need for scalable, quality-controlled production and dependable batch consistency, which helps explain why this segment continues to command the largest share.

Instruments are emerging as the fastest-growing product category in the in vitro diagnostics contract manufacturing market because demand is increasingly tied to more sophisticated testing platforms and the need to commercialize integrated diagnostic systems efficiently. Compared with reagents and consumables, instrument manufacturing typically requires greater engineering coordination, specialized production capabilities, and tighter integration between design and scale-up, making contract partners more valuable as companies seek faster execution. That practical need for external expertise is a key reason Instruments are gaining momentum in the in vitro diagnostics contract manufacturing market.

Service Segment Analysis: Manufacturing Services (Largest Segment) vs Assay Development Services (Fastest-Growing Segment)

Manufacturing Services accounted for the largest share of the in vitro diagnostics contract manufacturing market in 2025, reflecting the core role of outsourced production in supporting commercial diagnostic supply. The segment’s leadership is grounded in the operational demands of regulated, high-volume manufacturing, where clients rely on external partners for process control, production continuity, and the ability to meet ongoing supply requirements without building full in-house capacity. That central production function keeps Manufacturing Services at the forefront of the in vitro diagnostics contract manufacturing market.

Assay Development Services represent the fastest-growing service area in the in vitro diagnostics contract manufacturing market as diagnostic companies increasingly look for external support earlier in the product lifecycle. Growth is being driven by the practical advantage of working with specialized partners that can help translate assay concepts into manufacturable, validated formats more efficiently than fragmented internal efforts. Relative to established manufacturing work, this service is gaining momentum because it directly addresses the need to accelerate development timelines while improving readiness for later-scale production in the in vitro diagnostics contract manufacturing market.